Evidence map›Paper›PMID 26472929›Full record

ArticleThe Journal of biological chemistry2016

Bone Morphogenetic Protein-2 (BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling.

Chandi C Mandal, Falguni Das, Suthakar Ganapathy, Stephen E Harris, Goutam Ghosh Choudhury, Nandini Ghosh-Choudhury

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. CaMKII inhibition due to TRIC-B loss-of-function dysregulates SMAD signaling in osteogenesis imperfecta.Matrix biology : journal of the International Society for Matrix Biology · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. The Role of BMP Signaling in Osteoclast Regulation.Journal of developmental biology · 2021
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. BMP-2 upregulates the AKT/mTOR pathway in breast cancer with microcalcification and indicates a poor prognosis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chandi C MandalDepartments of Pathology.
Falguni DasMedicine, and.
Suthakar GanapathyDepartments of Pathology.
Stephen E HarrisPeriodontics, University of Texas Health Science Center, San Antonio, Texas 78229.
Goutam Ghosh ChoudhuryMedicine, and From Veterans Affairs Research and Geriatric Research Education and Clinical Center, South Texas Veterans Health Care System and.
Nandini Ghosh-ChoudhuryDepartments of Pathology, From Veterans Affairs Research and choudhury@uthscsa.edu.
South Texas Veterans Health Care System · USThe University of Texas Health Science Center at San Antonio · US

Funding

Mechanism of Renal Cell Injury in DiabetesR01DK050190 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GHOSH CHOUDHURY, GOUTAM · 2004 to 2013
$2.3M
Redox Signaling in Osteoblast DifferentiationR01AR052425 · NIAMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GHOSH-CHOUDHURY, NANDINI · 2005 to 2009
$1.1M
NIAMS NIH HHS R01 AR052425NIAMS NIH HHS R01 AR52425NIDDK NIH HHS R01 DK050190NIDDK NIH HHS R01 DK50190
6 · The paper itself

Abstract

Bone remodeling is controlled by dual actions of osteoclasts (OCs) and osteoblasts (OBs). The calcium-sensitive nuclear factor of activated T cells (NFAT) c1 transcription factor, as an OC signature gene, regulates differentiation of OCs downstream of bone morphogenetic protein-2 (BMP-2)-stimulated osteoblast-coded factors. To analyze a functional link between BMP-2 and NFATc1, we analyzed bones from OB-specific BMP-2 knock-out mice for NFATc1 expression by immunohistochemical staining and found significant reduction in NFATc1 expression. This indicated a requirement of BMP-2 for NFATc1 expression in OBs. We showed that BMP-2, via the receptor-specific Smad pathway, regulates expression of NFATc1 in OBs. Phosphatidylinositol 3-kinase/Akt signaling acting downstream of BMP-2 also drives NFATc1 expression and transcriptional activation. Under the basal condition, NFATc1 is phosphorylated. Activation of NFAT requires dephosphorylation by the calcium-dependent serine/threonine phosphatase calcineurin. We examined the role of calcium in BMP-2-stimulated regulation of NFATc1 in osteoblasts. 1,2Bis(2aminophenoxy)ethaneN,N,N',N'-tetraacetic acid acetoxymethyl ester, an inhibitor of intracellular calcium abundance, blocked BMP-2-induced transcription of NFATc1. Interestingly, BMP-2 induced calcium release from intracellular stores and increased calcineurin phosphatase activity, resulting in NFATc1 nuclear translocation. Cyclosporin A, which inhibits calcineurin upstream of NFATc1, blocked BMP-2-induced NFATc1 mRNA and protein expression. Expression of NFATc1 directly increased its transcription and VIVIT peptide, an inhibitor of NFATc1, suppressed BMP-2-stimulated NFATc1 transcription, confirming its autoregulation. Together, these data show a role of NFATc1 downstream of BMP-2 in mouse bone development and provide novel evidence for the presence of a cross-talk among Smad, phosphatidylinositol 3-kinase/Akt, and Ca(2+) signaling for BMP-2-induced NFATc1 expression through an autoregulatory loop.

Indexed as

Gene Expression RegulationSignal TransductionActive Transport, Cell NucleusAnimalsBone Morphogenetic Protein 2CalcineurinCalcium Chelating AgentsCalcium SignalingCell LineCells, CulturedMiceMice, KnockoutNFATC Transcription FactorsOsteoblastsPhosphatidylinositol 3-KinasePhosphorylationAkt1 protein, mouseBmp2 protein, mouseBone Morphogenetic Protein 2CalcineurinCalcium Chelating AgentsNfatc1 protein, mouseNFATC Transcription FactorsPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-aktRecombinant ProteinsSmad5 ProteinSmad5 protein, mouseBMP-2bone morphogenetic protein (BMP)calcineurincalcium-calcineurin signalingNFATc1NFAT transcription factorosteoblastphosphatidylinositol 3-kinase (PI 3-kinase)Smad signalingSMAD transcription factor

Identifiers

PMID26472929
PMCPMC4714198
OpenAlexW2238472783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.